Vergoeding 2020-2024 voor ATC-subgroep N04BC : Dopamine-agonisten
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| N04BC01 Bromocriptine | 440 | . | . | . | . |
| N04BC04 Ropinirol (Requip ®) | 1.439.700 | 1.128.500 | 1.047.900 | 1.244.100 | 1.495.500 |
| N04BC05 Pramipexol (Sifrol ®) | 4.681.700 | 4.495.400 | 4.573.200 | 4.672.600 | 4.462.200 |
| N04BC07 Apomorfine (Apo-go ®) | 687.290 | 758.300 | 1.069.800 | 1.072.300 | 1.027.200 |
| N04BC09 Rotigotine (Neupro ®) | 2.572.000 | 2.573.600 | 2.640.900 | 2.727.900 | 2.862.900 |
| Totaal | 9.381.130 | 8.955.800 | 9.331.800 | 9.716.900 | 9.847.800 |